Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Levofloxacin; Azithromycin · 1 trial · 1 indication
| Name | Type | Description |
|---|---|---|
| Levofloxacin; Azithromycin | DRUG | - |
Inclusion Criteria: * Male or female * Healthy on the basis of a pre-study physical examination, medical history, and the laboratory results of blood hematology, biochemistry, and urinalysis performed within 24 hours before the first dose * Renal function tests must be within the normal laboratory ...
Levofloxacin and azithromycin are two antibiotic medications studied together in a Phase 1 trial. The trial evaluated bacteria in the mouth and throat of healthy adults before and after administration of either antibiotic. Both are small molecule drugs. The study was sponsored by Johnson & Johnson.
Johnson & Johnson, ticker JNJ, is the developer of the levofloxacin and azithromycin study. The company sponsored the Phase 1 trial evaluating these antibiotics in healthy volunteers.
The levofloxacin and azithromycin trial is in Phase 1. It has been completed, with 143 participants enrolled. The study was randomized but not double-blind and used an uncontrolled design. It is not currently active.
Levofloxacin and azithromycin were evaluated in clinical trial NCT00821782, titled "Evaluation of Bacteria in the Mouth and Throat of Healthy Adults Before and After the Administration of Either Levofloxacin or Azithromycin, Both Antibiotic Medications." The trial enrolled 143 healthy volunteers aged 18 years and older and has been completed.
Levofloxacin and azithromycin are antibiotics. In the completed Phase 1 trial, they were administered to healthy adults to evaluate bacteria in the mouth and throat before and after treatment. The specific indications for this combination are not disclosed.